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Abstract
Background: Cyclic vomiting syndrome (CVS), a chronic disorder characterized by recurrent episodes of vomiting,
is frequently unrecognized and is associated with high utilization of emergency department (ED) services.
Methods: A web-based survey was posted on the Cyclic Vomiting Syndrome Association (CVSA) website to assess
utilization of ED services in patients with CVS.
Results: Of 251 respondents, 104 (41.4%) were adult CVS patients and 147 (58.6%) were caregivers of pediatric and
adult patients. In the adult group, the median number of ED visits for CVS symptoms was 15(range 1 - 200), with a
median of 7 ED visits prior to a diagnosis of CVS (range 0 - 150). In the caregiver group, the median number of ED
visits was 10 (range 1 - 175) and the median number of ED visits prior to a diagnosis of CVS was 5 (range 0 - 65).
CVS was not diagnosed in the ED in 89/104 (93%) adults and 119/147 (93%) patients in the caregiver group. CVS
was not recognized in the ED in 84/95 (88%) of adults and 97/122 (80%) of patients in the caregiver group, despite
an established diagnosis of CVS.
Conclusion: There is a sub-group of adult and pediatric CVS patients who are high utilizers of ED services and CVS
is not recognized in the ED in the majority of patients. Improved efforts to educate ED physicians are indicated to
optimize treatment of patients with CVS and to decrease potential overuse of ED services.
Background
Cyclic vomiting syndrome (CVS) is a chronic idiopathic
functional gastrointestinal disorder that is characterized
by recurrent, stereotypical, disabling, discrete episodes
o fi n t e n s en a u s e aa n dv o m i t i n gt h a tl a s taf e wh o u r st o
days, interspersed with varying symptom-free intervals.
This disorder is primarily recognized in children, with
increasing recognition in adults. The pathophysiology of
CVS is unknown, but several theories have been
advanced including a dysfunctional brain-gut interaction
involving corticotrophin-releasing factor [1], dysregula-
tion of the autonomic nervous system and mitochon-
drial dysfunction [2-9].
The diagnosis of CVS in adults is based on Rome III
criteria: 1) Stereotypical episodes of vomiting regarding
onset (acute) and duration (less than 1 week); 2) Three
or more discrete episodes in the prior year; and 3)
Absence of nausea and vomiting between episodes and
absence of metabolic, gastrointestinal, central nervous
system structural or biochemical disorders. A personal
or family history of migraines is supportive of the diag-
nosis [10]. The differential diagnosis of CVS includes
various gastrointestinal, endocrine, neurological and
metabolic problems that can mimic CVS, e.g., hydrone-
phrosis and intestinal malrotation [11-13]. Unfortunately
CVS episodes are typically misdiagnosed and there is a
3-8 year delay in diagnosis in adults [14,15] and 2.5 year
d e l a yi nc h i l d r e n[ 1 6 ] .G i v e nt h ep r o b l e m sw i t hd i a g n o -
sis of this disorder, it is likely that CVS is more com-
mon than currently thought.
In addition, diagnostic uncertainty may lead to subopti-
mal acute care. Patients with CVS frequently seek care in,
or are referred to, the emergency department (ED) for
management of acute episodes of vomiting associated with
dehydration and electrolyte disturbances. Anecdotally, we
believe that familiarity with this disorder among ED per-
sonnel is low. The impact of this on acute management
and the quality of the patient experience is unclear.
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The aim of our study was to conduct a survey among
patients with CVS about their ED experiences, including
recognition of CVS by ED personnel and treatment
received in the ED.
Methods
Two questionnaires were designed for patients with CVS
who had visited an ED with symptoms of CVS - one for
self-completion by adults with CVS (see additional file
1) and a separate questionnaire for caregivers of patients
diagnosed with CVS (see additional file 1). Although
intended primarily for pediatric patients, the caregiver
survey could be completed by a parent or caregiver of
an adult CVS patient.
The survey included demographic information includ-
ing age, sex and race. Questions included: the total
number of ED visits, number of visits before and after
recognition of CVS, number of different EDs visited,
referral patterns from the ED, and protocols for care.
Recognition of CVS and treatment provided in the ED
was also assessed. The respondents included all patients
who visited the CVSA website and was unlikely to be
restricted to a particular geographic area or center.
The surveys were posted on the Web message board
of the Cyclic Vomiting Syndrome Association (CVSA)
for a period of three months. Patients or caregivers of
patients with any prior ED visit related to CVS were
invited to participate. The survey was run on http://
www.surveymonkey.com. The site and this survey are
fully compliant with the Checklist for Reporting Results
of Internet E-Surveys (CHERRIES) Web-survey guide-
lines [17]. Patients and caregivers could voluntarily
choose to complete the survey and the study was
approved by the Institutional Review Board at our
institution.
Results
There were 251 responses, of which 104 (41.4%) were
from adults with CVS and 147 (58.6%) were from care-
givers of patients with CVS. The majority of patients in
both groups were female and Caucasian (Table 1). Most
adult patients 55 (57%) initially presented with CVS
symptoms to the ED between the ages of 18-40 years
and in the caregiver group, 81 (62%) patients first pre-
sented to the ED between the ages of 2-11 years.
The total number of ED visits reported in this entire
population was 2,435 among 251 respondents. Approxi-
mately half of ED visits occurred prior to a diagnosis of
CVS being made and the recurrent pattern was not recog-
nized (Table 2). In 80% or more of patients, CVS was not
recognized in the ER both before and even after the diag-
nosis was established by a physician elsewhere (Table 2).
A minority of patients in the adult group, 31 (32.3%),
and 58 (41.7%) in the caregiver group, had protocols for
the care of CVS from their treating physician that the
patients brought with them to the ED. These protocols
consisted of specific instructions regarding management of
acute episodes of CVS in the ED by the primary physician/
specialist. Among patients who presented to the ED with a
protocol for emergency management of CVS, (25/31)81%
of adults and (45/58) 80% of patients in the caregiver
group had the protocol completely or partially followed.
The large majority of patients in both groups - 87/104
(84%) of adults and 109/147(74%) of patients in the care-
giver group - usually received intravenous fluids as stan-
dard care in the ED. Of patients who responded to the
question about referral from the ED, approximately a third
of the patients in each of the groups who were seen in the
ED for CVS symptoms were not referred to specialists for
further evaluation of their symptoms (Figures 1 and 2).
Discussion
This study found that patients with CVS reported that
the cause of their symptoms was frequently unrecognized
Table 1 Characteristics of patients with CVS
Adult group: n = 104 Caregiver group: n = 147
Age 18-24 years 20 (27.7%) 2-5 years 16 (13.7%)
25-39 years 26 (36.1%) 6-11 years 43 (36.8%)
40-65 years 26 (36.1%) 12-17 years 30 (25.6%)
>18 years 28 (23.9%)
Gender
Female 40 (66.7%) 60 (63.8%)
Male 20 (33.3%) 34 (36.2%)
Race
White 66 (89.2%) 105 (86.8%)
Other 8 (10.8%) 15 (12.5%)
Table 2 Characteristics of ER visits in patients with CVS
Adults:
n = 104
Caregiver group:
n = 147
Number of ER visits per patient with
CVS (Median, Range)
15 (1-200) 10 (1-175)
Number of ER visits per patient prior
to a diagnosis of CVS being made
(Median, Range)
7 (1-150) 5 (0-65)
Diagnosis NOT made in the ER 89(93%) 119(93)%
Diagnosis NOT recognized by the
ER in patients with an established
diagnosis of CVS
84(88%) 97(80%)
Number of different ERs visited
(Mean ± SD)
4.69 ± 4.72 2.6 ± 2.42
ED = emergency department
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established diagnosis. The differences in the number of
ED visits before diagnosis in children and adults are likely
a reflection of the awareness of CVS amongst pediatri-
cians and adult physicians. Though CVS was first
d e s c r i b e di nc h i l d r e ni nt h e1 9
th century, it still remains
largely unrecognized in adults despite increasing evi-
dence to the contrary. This is likely due to inadequate
knowledge and understanding about the disease and the
relative paucity of literature on this disorder especially
amongst adult physicians.
Half of the ED visits in our study population occurred
prior to the diagnosis; under-recognition likely contribu-
ted to this significant delay in diagnosis, as individual
episodes may have been attributed to acute viral ill-
nesses or other causes. Delay in making the correct
diagnosis results in a lack of preventive care, and
may lead to unnecessary interventions, both diagnostic
(e.g., endoscopy) and therapeutic (e.g., cholecystectomy)
in both adults and children [15].
Even though CVS was not recognized by ED person-
nel even when patients already bore the diagnosis, the
vast majority of all CVS patients received intravenous
fluids, an appropriate intervention in patients with dehy-
dration from vomiting of any cause. However, we can-
n o tt e l lf r o mo u rr e s u l t sw h e t h e rd e x t r o s e - c o n t a i n i n g
fluids were used or not; this may be important since
dextrose-containing intravenous fluids may be therapeu-
tic in the management of acute CVS episodes [11]. It is
also encouraging that 80% of patients who presented to
the ED with a protocol for acute management of CVS
had their protocols followed. Unfortunately only a min-
ority of patients had such care protocols from their phy-
sicians. This should prompt physicians who take care of
CVS patients to collaborate with ED physicians in estab-
lishing individualized protocols for acute management
of CVS episodes.
Our patients with CVS had a substantial number of
ED visits with high rates of utilization of ED services. In
addition to generating an enormous number of ED vis-
its, these patients visited at least four separate EDs on
average and this may be an attempt by the patient to
seek out effective medical care. Despite repeated visits,
the majority of patients in this study were not referred
to gastroenterologists.
Inappropriate referrals or non-referrals can lead to
further ED visits and also a significant delay in the insti-
tution of preventive therapy. The therapy of this disease
is very similar to migraine headaches and includes pre-
ventive therapies (e.g. amitriptyline), abortive therapy
with triptans and supportive strategies (intravenous
hydration and sedation) [18,19]. It has been shown that
establishing a diagnosis and providing appropriate treat-
ment has a good response in patients with CVS [15].
The economic impact of individual ED visits is stag-
gering and data from our institution indicate that there
were 131 visits for CVS in the year 2008. With the cost
of a single ED visit being US $2880, the cost of ED
management of CVS in our hospital alone would
amounts to US $ 377,000 in one year. For cost-effective
care it is crucial that steps be taken to address this issue
including education about CVS amongst ED personnel
and the medical community and further research on
newer therapies for CVS. Further efforts in this regard
will not only alleviate patient suffering but can poten-
tially transform into saving of hundreds of thousands of
dollars.
There are several important limitations of this study.
First, all data are self-reported, and therefore subject
to recall bias. While such information is reflective of
the patient experience, details may not be completely
accurate. For example, it is possible that ED personnel
No referrals, 30
Ob-gyn, 1
Neurology, 4
Internal Medicine, 
6
Psychiatry, 7
Family Medicine, 
14
Gastroenterology, 
31
Figure 1 Emergency room referral patterns of adult patients
with cyclic vomiting syndrome. This figure shows the actual
numbers of patients (n = 93) who were either referred or not
referred to other specialists; Ob-Gyn = Obstetrics and Gynecology.
Gastroenterology, 
38
No referrals, 35
Family Medicine, 9
Internal Medicine, 6
Neurology, 4
Psychiatry, 1
Figure 2 Emergency department referral patterns of patients
in the caregiver group with cyclic vomiting syndrome. This
figure shows the actual numbers of patients (n = 93) who were
either referred or not referred to other specialists.
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communicated this understanding to the patient or
caregiver. Respondents, who were identified through
the CVSA Web site, may be a select group of patients
who are more knowledgeable about CVS, or who have
had negative experiences prompting their participa-
tion. CVSA members could also be more likely to
h a v eam o r es e v e r ec o u r s et h a no t h e r sw i t hC V S ,
although, arguably it is this very subset of patients
that needs to be targeted as they utilize enormous
health care resources. It is even possible that some
respondents do not actually have CVS, but we believe
this is unlikely as non-CVS patients would have little
incentive to visit the CVSA Web site and participate
in the survey.
Also, since this survey only included patients with
CVS who had visited an ED, we were unable to ascer-
tain what proportion of CVS patients use the ED or the
factors that lead to frequent ED use among patients
with CVS. However in the author’s own cohort of over
a hundred patients with CVS, 13% of patients presented
to the ED > 12 times a year (unpublished data). In an
effort to protect the personal health information of
these patients we did not attempt to obtain geographic
location. We are unable to comment about other factors
that may be important with regard to ED use among
CVS patients such as seasonality or whether these
patients were cared for in academic or non-academic
centers.
Conclusions
We conclude that the experience of CVS patients with
acute episodes treated in the ED is suboptimal, with
delays in recognition and referral, and infrequent use of
patient-specific treatment protocols.
Because patients with CVS often present to the ED
during acute episodes, ED providers should be familiar
with their potential role in this condition: consideration
of CVS as a diagnosis in any patient with a history of
repeated high-intensity vomiting episodes; supportive
care with hydration, dextrose containing fluids, and
anti-emetic therapy; and initiation of appropriate refer-
rals from the ED to gastroenterologists or specialists
with expertise in this disorder. Care for CVS patients
may be improved through education of emergency phy-
sicians and staff about this condition and its
management.
Additional file 1: Web survey for patients and caregivers of patients
with CVS. Original web survey used to gather data from patients with
CVS.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-227X-10-4-
S1.PDF]
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